Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

ProPhase Labs Total Liabilities 2010-2025 | PRPH

ProPhase Labs total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
  
ProPhase Labs Annual Total Liabilities
(Millions of US $)
2024 $56
2023 $43
2022 $24
2021 $31
2020 $21
2019 $1
2018 $4
2017 $2
2016 $7
2015 $6
2014 $5
2013 $5
2012 $5
2011 $8
2010 $8
2009 $7
ProPhase Labs Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $35
2024-12-31 $56
2024-09-30 $54
2024-06-30 $50
2024-03-31 $45
2023-12-31 $43
2023-09-30 $35
2023-06-30 $32
2023-03-31 $35
2022-12-31 $24
2022-09-30 $30
2022-06-30 $30
2022-03-31 $33
2021-12-31 $31
2021-09-30 $24
2021-06-30 $29
2021-03-31 $33
2020-12-31 $21
2020-09-30 $12
2020-06-30 $1
2020-03-31 $1
2019-12-31 $1
2019-09-30 $1
2019-06-30 $1
2019-03-31 $1
2018-12-31 $4
2018-09-30 $1
2018-06-30 $2
2018-03-31 $2
2017-12-31 $2
2017-09-30 $3
2017-06-30 $4
2017-03-31 $8
2016-12-31 $7
2016-09-30 $6
2016-06-30 $5
2016-03-31 $6
2015-12-31 $6
2015-09-30 $4
2015-06-30 $4
2015-03-31 $6
2014-12-31 $5
2014-09-30 $7
2014-06-30 $6
2014-03-31 $4
2013-12-31 $5
2013-09-30 $5
2013-06-30 $5
2013-03-31 $4
2012-12-31 $5
2012-09-30 $7
2012-06-30 $6
2012-03-31 $7
2011-12-31 $8
2011-09-30 $8
2011-06-30 $6
2011-03-31 $7
2010-12-31 $8
2010-09-30 $8
2010-06-30 $6
2010-03-31 $7
2009-12-31 $7
2009-09-30 $6
2009-06-30 $6
2009-03-31 $6
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.013B $0.007B
ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Its consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE?, a zinc gluconate glycine product. COLD-EEZE? family of lozenges and sugar free tablets reduce the severity and duration of the common cold. Its customers include wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs is also engaged in the research and development of potential natural base health products along with supplements and cosmeceuticals for human and veterinary use. The Company is headquartered in Doylestown, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $67.696B 26.04
Zoetis (ZTS) United States $65.303B 23.69
Daiichi Sankyo, - (DSNKY) Japan $46.222B 23.69
Takeda Pharmaceutical (TAK) Japan $45.947B 9.38
BeOne Medicines - (ONC) Cayman Islands $31.585B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.846B 0.00
Summit Therapeutics (SMMT) United States $21.285B 0.00
Merck (MKKGY) Germany $16.407B 10.67
Shionogi (SGIOY) Japan $15.227B 15.26
United Therapeutics (UTHR) United States $13.600B 11.77
Neurocrine Biosciences (NBIX) United States $12.399B 36.99
Orion OYJ (ORINY) Finland $10.757B 25.93
IPSEN (IPSEY) France $10.413B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.676B 0.00
Corcept Therapeutics (CORT) United States $7.618B 63.98
Grifols, S.A (GRFS) Spain $7.329B 0.00
Stevanato Group S.p.A (STVN) Italy $7.156B 42.20
Ionis Pharmaceuticals (IONS) United States $6.637B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $4.376B 0.00
Hypermarcas (HYPMY) Brazil $2.869B 21.57
NewAmsterdam Pharma (NAMS) Netherlands $2.842B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.677B 12.75
Crinetics Pharmaceuticals (CRNX) United States $2.514B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.422B 8.14
Centessa Pharmaceuticals (CNTA) United Kingdom $2.274B 0.00
Ocular Therapeutix (OCUL) United States $2.124B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.742B 0.00
ARS Pharmaceuticals (SPRY) United States $1.719B 0.00
Dyne Therapeutics (DYN) United States $1.588B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.497B 22.29
Evotec AG (EVO) Germany $1.396B 0.00
Guardian Pharmacy Services (GRDN) United States $1.264B 0.00
Harrow (HROW) United States $1.263B 0.00
Ardelyx (ARDX) United States $1.256B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.233B 0.00
Collegium Pharmaceutical (COLL) United States $1.122B 6.01
Xeris Biopharma Holdings (XERS) United States $1.070B 0.00
Akebia Therapeutics (AKBA) United States $0.898B 0.00
Cronos Group (CRON) Canada $0.883B 0.00
Enliven Therapeutics (ELVN) United States $0.868B 0.00
ProKidney (PROK) United States $0.758B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.681B 0.00
Zevra Therapeutics (ZVRA) United States $0.657B 0.00
Siga Technologies (SIGA) United States $0.642B 7.93
Elite Pharmaceuticals (ELTP) United States $0.626B 0.00
KalVista Pharmaceuticals (KALV) United States $0.620B 0.00
Organogenesis (ORGO) United States $0.578B 0.00
Theravance Biopharma (TBPH) United States $0.576B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.569B 5.86
Bioventus (BVS) United States $0.568B 13.84
Relay Therapeutics (RLAY) United States $0.552B 0.00
Tourmaline Bio (TRML) United States $0.532B 0.00
USANA Health Sciences (USNA) United States $0.527B 10.81
Xencor (XNCR) United States $0.516B 0.00
Oruka Therapeutics (ORKA) United States $0.490B 0.00
Savara (SVRA) United States $0.456B 0.00
Aquestive Therapeutics (AQST) United States $0.387B 0.00
Esperion Therapeutics (ESPR) United States $0.371B 0.00
Nanobiotix S.A (NBTX) France $0.348B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.342B 0.00
AleAnna (ANNA) United States $0.325B 0.00
Aldeyra Therapeutics (ALDX) United States $0.315B 0.00
Larimar Therapeutics (LRMR) United States $0.296B 0.00
Nektar Therapeutics (NKTR) United States $0.286B 0.00
Altimmune (ALT) United States $0.280B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 17.82
Galectin Therapeutics (GALT) United States $0.263B 0.00
4D Molecular Therapeutics (FDMT) United States $0.261B 0.00
OmniAb (OABI) United States $0.241B 0.00
Heron Therapeutics (HRTX) United States $0.201B 0.00
MediWound (MDWD) Israel $0.201B 0.00
China SXT Pharmaceuticals (SXTC) China $0.184B 0.00
Aclaris Therapeutics (ACRS) United States $0.177B 0.00
Journey Medical (DERM) United States $0.176B 0.00
Lyell Immunopharma (LYEL) United States $0.170B 0.00
MEI Pharma (MEIP) United States $0.168B 0.00
Profound Medical (PROF) Canada $0.166B 0.00
Lexeo Therapeutics (LXEO) United States $0.150B 0.00
Korro Bio (KRRO) United States $0.150B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.145B 22.42
Protara Therapeutics (TARA) United States $0.121B 0.00
Liminatus Pharma (LIMN) United States $0.115B 0.00
Avita Medical (RCEL) United States $0.112B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Inhibikase Therapeutics (IKT) United States $0.106B 0.00
Cassava Sciences (SAVA) United States $0.105B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.103B 0.00
Avalo Therapeutics (AVTX) United States $0.097B 0.00
Champions Oncology (CSBR) United States $0.088B 20.03
VAXART, INC (VXRT) United States $0.087B 0.00
Achieve Life Sciences (ACHV) Canada $0.087B 0.00
ESSA Pharma (EPIX) Canada $0.085B 0.00
Dominari Holdings (DOMH) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Surrozen (SRZN) United States $0.082B 0.00
Vivani Medical (VANI) United States $0.082B 0.00
Cardiol Therapeutics (CRDL) Canada $0.082B 0.00
Nutriband (NTRB) United States $0.080B 0.00
PMV Pharmaceuticals (PMVP) United States $0.077B 0.00
Metagenomi (MGX) United States $0.072B 0.00
BioNxt Solutions (BNXTF) Canada $0.071B 0.00
Assertio Holdings (ASRT) United States $0.070B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.065B 0.00
Inotiv (NOTV) United States $0.063B 0.00
Wellgistics Health (WGRX) United States $0.061B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
DURECT (DRRX) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Rafael Holdings (RFL) United States $0.057B 0.00
Unicycive Therapeutics (UNCY) United States $0.052B 0.00
PolyPid (PYPD) Israel $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 29.36
Plus Therapeutics (PSTV) United States $0.048B 0.00
Fractyl Health (GUTS) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Gain Therapeutics (GANX) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.044B 0.00
NRx Pharmaceuticals (NRXP) United States $0.044B 0.00
Klotho Neurosciences (KLTO) United States $0.042B 0.00
Jupiter Neurosciences (JUNS) United States $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
FibroGen (FGEN) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Karyopharm Therapeutics (KPTI) United States $0.034B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
Enlivex Therapeutics (ENLV) Israel $0.034B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Mural Oncology (MURA) Ireland $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
Incannex Healthcare (IXHL) Australia $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
BioVie (BIVI) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 12.36
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.15
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00